Search

A recent study conducted at the First Affiliated Hospital of Anhui Medical University in China explored the use of dexmedetomidine as an adjuvant to spinal-epidural anesthesia for cesarean section surgery. The study involved 60 participants who were randomly assigned to receive either dexmedetomidine or a placebo. The results showed that the group receiving dexmedetomidine experienced lower pain scores and longer analgesic duration compared to the placebo group. The researchers concluded that the use of dexmedetomidine as an adjuvant could effectively extend the analgesic duration of ropivacaine to 24 hours following cesarean surgery. [Extracted from the article]